Organogenesis Holdings Inc. (ORGO) stock
ORGONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.81+0.01 (+1.06%)
Close on Nov 17, 2026Market cap $104.43MP/E –Yield –
Organogenesis cash
Cash and short-term investments held at the end of each period.
Organogenesis's cash was $46.10M at Jun 30, 2026. For fiscal 2025 it was $93.68M, down 31.2% from the year before. Over ten years it grew 54.6% a year on average. The highest annual figure on record is $136.15M in fiscal 2024.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $93.68M | -31.2% |
| FY2024 | Dec 31, 2024 | $136.15M | +30.5% |
| FY2023 | Dec 31, 2023 | $104.34M | +1.0% |
| FY2022 | Dec 31, 2022 | $103.29M | -9.8% |
| FY2021 | Dec 31, 2021 | $114.53M | +35.0% |
| FY2020 | Dec 31, 2020 | $84.81M | +40.5% |
| FY2019 | Dec 31, 2019 | $60.37M | +182.0% |
| FY2018 | Dec 31, 2018 | $21.41M | +807.8% |
| FY2017 | Dec 31, 2017 | $2.36M | +26.9% |
| FY2016 | Dec 31, 2016 | $1.86M | +55.0% |
| FY2015 | Dec 31, 2015 | $1.20M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $46.10M | -37.5% |
| Q1 FY2026 | Mar 31, 2026 | $91.38M | -17.3% |
| Q4 FY2025 | Dec 31, 2025 | $93.68M | -31.2% |
| Q3 FY2025 | Sep 30, 2025 | $63.75M | -32.8% |
| Q2 FY2025 | Jun 30, 2025 | $73.74M | -18.5% |
| Q1 FY2025 | Mar 31, 2025 | $110.53M | +23.7% |
| Q4 FY2024 | Dec 31, 2024 | $136.15M | +30.5% |
| Q3 FY2024 | Sep 30, 2024 | $94.93M | -3.9% |
| Q2 FY2024 | Jun 30, 2024 | $90.48M | +1.1% |
| Q1 FY2024 | Mar 31, 2024 | $89.35M | -0.1% |
| Q4 FY2023 | Dec 31, 2023 | $104.34M | +1.0% |
| Q3 FY2023 | Sep 30, 2023 | $98.83M | -8.5% |
| Q2 FY2023 | Jun 30, 2023 | $89.51M | -20.8% |
| Q1 FY2023 | Mar 31, 2023 | $89.42M | -17.6% |
| Q4 FY2022 | Dec 31, 2022 | $103.29M | -9.8% |
| Q3 FY2022 | Sep 30, 2022 | $108.02M | +5.2% |
| Q2 FY2022 | Jun 30, 2022 | $112.94M | +25.1% |
| Q1 FY2022 | Mar 31, 2022 | $108.50M | +39.2% |
| Q4 FY2021 | Dec 31, 2021 | $114.53M | +35.0% |
| Q3 FY2021 | Sep 30, 2021 | $102.72M | +178.5% |
| Q2 FY2021 | Jun 30, 2021 | $90.31M | +121.6% |
| Q1 FY2021 | Mar 31, 2021 | $77.96M | +65.6% |
| Q4 FY2020 | Dec 31, 2020 | $84.81M | +40.5% |
| Q3 FY2020 | Sep 30, 2020 | $36.89M | +59.3% |
| Q2 FY2020 | Jun 30, 2020 | $40.75M | +102.2% |
| Q1 FY2020 | Mar 31, 2020 | $47.07M | +53.5% |
| Q4 FY2019 | Dec 31, 2019 | $60.37M | +182.0% |
| Q3 FY2019 | Sep 30, 2019 | $23.16M | -10.5% |
| Q2 FY2019 | Jun 30, 2019 | $20.16M | +1438.9% |
| Q1 FY2019 | Mar 31, 2019 | $30.66M | +3240.2% |
| Q4 FY2018 | Dec 31, 2018 | $21.41M | +807.8% |
| Q3 FY2018 | Sep 30, 2018 | $25.89M | +21888.8% |
| Q2 FY2018 | Jun 30, 2018 | $1.31M | +357.3% |
| Q1 FY2018 | Mar 31, 2018 | $918.00K | +88.8% |
| Q4 FY2017 | Dec 31, 2017 | $2.36M | +26.9% |
| Q3 FY2017 | Sep 30, 2017 | $117.73K | -31.5% |
| Q2 FY2017 | Jun 30, 2017 | $286.46K | – |
| Q1 FY2017 | Mar 31, 2017 | $486.20K | – |
| Q4 FY2016 | Dec 31, 2016 | $1.86M | – |
| Q3 FY2016 | Sep 30, 2016 | $171.83K | – |
See a number that looks wrong?